Journal article
In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada
Abstract
OBJECTIVE: The aim of this study was to evaluate the in vitro disintegration of the five newly available Canadian generic risedronate 35 mg tablets compared to the innovator (branded) product, ACTONEL * *ACTONEL is a registered trade name of Warner Chilcott Company, LLC. (risedronate sodium) 35 mg.
RESEARCH DESIGN AND METHODS: Tablets were inspected for colour and appearance. Disintegration times were determined using United States Pharmacopeia …
Authors
Walker AD; Adachi JD
Journal
Current Medical Research and Opinion, Vol. 27, No. 9, pp. 1749–1754
Publisher
Taylor & Francis
Publication Date
September 1, 2011
DOI
10.1185/03007995.2011.604309
ISSN
0300-7995